✦ LIBER ✦

Morbidity and mortality in the Italian Gastric Cancer Study Group randomized clinical trial of D1 versus D2 resection for gastric cancer

✍ Scribed by M. Degiuli; M. Sasako; A. Ponti

Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 123 KB
Volume: 97
Category: Article
ISSN: 0007-1323
DOI: 10.1002/bjs.6936

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Randomized clinical trial of morbidity a

Randomized clinical trial of morbidity after D1 and D3 surgery for gastric cancer

✍ C. W. Wu; C. A. Hsiung; S. S. Lo; M. C. Hsieh; L. T. Shia; J. Whang-Peng 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 104 KB 👁 1 views

Randomized clinical trial of Ligasure™ v

Randomized clinical trial of Ligasure™ versus conventional surgery for extended gastric cancer resection

✍ W.-J. Lee; T.-C. Chen; I-R. Lai; W. Wang; M.-T. Huang 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 119 KB 👁 1 views

The combination of cisplatin, doxorubici

The combination of cisplatin, doxorubicin, and mitomycin (PAM) compared with the FAM regimen in treating advanced gastric carcinoma: A phase II randomized trial of the Italian oncology group for clinical research

✍ Vincenzo De Lisi; Giorgio Cocconi; Francesco Angelini; Francesco Cavicchi; Franc 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 482 KB 👁 2 views

## BACKGROUND. In a randomized Phase I1 study, the authors evaluated the activity and toxicity of the new cisplatin, doxorubicin, and mitomycin C (PAM) comhination, that includes cisplatin (P) instead of 5-fluorouracil as in the 5-fluorouracil, doxorubicin, and mitomycin C (FAM) Combination, in pat